Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Alnylam to Webcast Presentation at 42nd Annual J.P. Morgan Healthcare Conference


Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview and participate in a Q&A session at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 9:45 am PT (12:45 pm ET) at The Westin St. Francis in San Francisco. This presentation will include an update on unaudited fourth quarter and full year 2023 global net product revenues.

A live audio webcast of both the presentation and Q&A session will be available on the Investors section of the Company's website, www.alnylam.com/events. A replay will be available on the Alnylam website within 48 hours after the event.

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and prevalent diseases with unmet need. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach yielding transformative medicines. Since its founding in 2002, Alnylam has led the RNAi Revolution and continues to deliver on a bold vision to turn scientific possibility into reality. Alnylam's commercial RNAi therapeutic products are ONPATTRO® (patisiran), AMVUTTRA® (vutrisiran), GIVLAARI® (givosiran), OXLUMO® (lumasiran), and Leqvio® (inclisiran), which is being developed and commercialized by Alnylam's partner, Novartis. Alnylam has a deep pipeline of investigational medicines, including multiple product candidates that are in late-stage development. Alnylam is executing on its "Alnylam P5x25" strategy to deliver transformative medicines in both rare and common diseases benefiting patients around the world through sustainable innovation and exceptional financial performance, resulting in a leading biotech profile. Alnylam is headquartered in Cambridge, MA. For more information about our people, science and pipeline, please visit www.alnylam.com and engage with us on X (formerly Twitter) at @Alnylam, or on LinkedIn, Facebook, or Instagram.


These press releases may also interest you

at 14:15
Ediscovery Software Market size is set to grow by USD 13.57 billion from 2024-2028, Rising volume of electronic data to boost the market growth, Technavio
The global Ediscovery software market  size is estimated to grow by USD 13.57 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  15.7%  during the forecast period.  Rising volume of electronic data is...

at 14:03
Maximizing Efficiency and Innovation in Food & Beverage Manufacturing Through Exponential IT Transformation: New Research From Info-Tech Research Group
New research insights from Info-Tech Tech Research Group will equip food and beverage manufacturers with essential strategies for embracing digital transformation. The global research and advisory firm explains that the industry can significantly...

at 13:51
realme Unveils Its Ultra Clear Camera with AI, the realme 13 Pro Series, Pioneering a New Era in AI Imaging
realme, the world's fastest-growing smartphone brand, today unveiled its highly anticipated ultra clear camera with AI, the realme 13 Pro Series, at the realme AI Imaging Media Preview Event in Bangkok....

at 13:30
The Government of Canada is taking steps to address plastic waste and pollution from the textile and apparel sector
Textiles is the fifth-largest category of plastic waste sent to landfills in Canada. Furthermore, through regular wear and tear and when washed, synthetic clothing sheds plastic microfibres?tiny thread-like fibres that become microplastic pollution....

at 13:22
The TADROS brothers, founders of Liberty City, from Montreal, Canada receive the support of a globally recognized billionaire from Silicon Valley for a technology project in Quebec
ÉRIC & DANIEL TADROS, the visionaries behind the Liberty City real estate development, have received support from Tim Draper, a venture capitalist who initially funded Elon Musk for Tesla and SpaceX, and also supported over 20 companies that now...

at 13:13
Beatbot Celebrates Market Leadership with Early Amazon Prime Day Launch and Unbeatable Discounts
Beatbot, the brand behind the world's most innovative pool-cleaning robots, is excited to announce its biggest consumer sale in brand history for Amazon Prime Day 2024. The brand's markdown of smart home technology will run between July 6 and July...

More news about Science and technology...


News published on and distributed by: